Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 938

1.

A rapid diagnostic test for human Visceral Leishmaniasis using novel Leishmania antigens in a Laser Direct-Write Lateral Flow Device.

Humbert MV, Costa LE, Katis I, Fonseca Ramos F, Sanchéz Machado A, Sones C, Ferraz Coelho EA, Christodoulides M.

Emerg Microbes Infect. 2019;8(1):1178-1185. doi: 10.1080/22221751.2019.1635430.

PMID:
31381478
2.

Screening for pulmonary arterial hypertension in systemic sclerosis.

Weatherald J, Montani D, Jevnikar M, Jaïs X, Savale L, Humbert M.

Eur Respir Rev. 2019 Jul 31;28(153). pii: 190023. doi: 10.1183/16000617.0023-2019. Print 2019 Sep 30.

3.

Characterization of Kcnk3-Mutated Rat, a Novel Model of Pulmonary Hypertension.

Lambert M, Capuano V, Boet A, Tesson L, Bertero T, Nakhleh MK, Remy S, Anegon I, Péchoux C, Hautefort A, Rücker-Martin C, Manoury B, Domergue V, Mercier O, Girerd B, Montani D, Perros F, Humbert M, Antigny F.

Circ Res. 2019 Jul 26. doi: 10.1161/CIRCRESAHA.119.314793. [Epub ahead of print]

PMID:
31347976
4.

Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous.

Perros F, Sentenac P, Boulate D, Manaud G, Kotsimbos T, Lecerf F, Lamrani L, Fadel E, Mercier O, Londono-Vallejo A, Humbert M, Eddahibi S.

Int J Mol Sci. 2019 Jul 22;20(14). pii: E3575. doi: 10.3390/ijms20143575.

5.

Outpatient management of patients with low-risk pulmonary embolism: another piece of evidence.

Sanchez O, Humbert M.

Eur Heart J. 2019 Jul 13. pii: ehz484. doi: 10.1093/eurheartj/ehz484. [Epub ahead of print] No abstract available.

PMID:
31302693
6.

Characterization of two putative Dichelobacter nodosus footrot vaccine antigens identifies the first lysozyme inhibitor in the genus.

Humbert MV, Jackson A, Orr CM, Tews I, Christodoulides M.

Sci Rep. 2019 Jul 11;9(1):10055. doi: 10.1038/s41598-019-46506-z.

7.

Severe T2-high asthma in the biologics era: European experts' opinion.

Pavord I, Bahmer T, Braido F, Cosío BG, Humbert M, Idzko M, Adamek L.

Eur Respir Rev. 2019 Jul 8;28(152). pii: 190054. doi: 10.1183/16000617.0054-2019. Print 2019 Jun 30. Review.

8.

High Glass-Transition Temperature Polymer Networks Harnessing the Dynamic Ring Opening of Pinacol Boronates.

Brunet J, Collas F, Humbert M, Perrin L, Brunel F, Lacôte E, Montarnal D, Raynaud J.

Angew Chem Int Ed Engl. 2019 Jun 26. doi: 10.1002/anie.201904559. [Epub ahead of print] Review.

PMID:
31241821
9.

Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility.

Humbert M, Albers FC, Bratton DJ, Yancey SW, Liu MC, Hozawa S, Llanos JP, Kwon N.

Respir Med. 2019 Jul - Aug;154:69-75. doi: 10.1016/j.rmed.2019.06.004. Epub 2019 Jun 8.

PMID:
31220806
10.

Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.

Bordenave J, Thuillet R, Tu L, Phan C, Cumont A, Marsol C, Huertas A, Savale L, Hibert M, Galzi JL, Bonnet D, Humbert M, Frossard N, Guignabert C.

Cardiovasc Res. 2019 Jun 7. pii: cvz153. doi: 10.1093/cvr/cvz153. [Epub ahead of print]

PMID:
31173066
11.

Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.

Antigny F, Chaumais MC, Humbert M, Montani D.

Fundam Clin Pharmacol. 2019 Aug;33(4):426-427. doi: 10.1111/fcp.12489. Epub 2019 Jun 26. No abstract available.

PMID:
31148228
12.

Cloning, Expression, and Purification of Recombinant Neisseria gonorrhoeae Proteins.

Humbert MV.

Methods Mol Biol. 2019;1997:233-266. doi: 10.1007/978-1-4939-9496-0_15.

PMID:
31119628
13.

Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?

Margelidon-Cozzolino V, Delavenne X, Catella-Chatron J, De Magalhaes E, Bezzeghoud S, Humbert M, Montani D, Bertoletti L.

Blood Rev. 2019 Sep;37:100579. doi: 10.1016/j.blre.2019.05.003. Epub 2019 May 15. Review.

PMID:
31113643
14.

Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension.

Taniguchi Y, Jaïs X, Jevnikar M, Boucly A, Weatherald J, Brenot P, Planche O, Parent F, Savale L, Fadel E, Montani D, Humbert M, Sitbon O, Simonneau G.

J Heart Lung Transplant. 2019 Aug;38(8):833-842. doi: 10.1016/j.healun.2019.04.006. Epub 2019 Apr 27.

PMID:
31103383
15.

Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.

Hoette S, Creuzé N, Rochitte CE, Simonneau G, Humbert M, Souza R, Chemla D.

Pulmonology. 2019 Jul - Aug;25(4):248-251. doi: 10.1016/j.pulmoe.2019.03.002. Epub 2019 May 10.

16.

Prostacyclin for pulmonary arterial hypertension.

Barnes H, Yeoh HL, Fothergill T, Burns A, Humbert M, Williams T.

Cochrane Database Syst Rev. 2019 May 1;5:CD012785. doi: 10.1002/14651858.CD012785.pub2. Review.

PMID:
31042010
17.

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Brenot P, Jaïs X, Taniguchi Y, Garcia Alonso C, Gerardin B, Mussot S, Mercier O, Fabre D, Parent F, Jevnikar M, Montani D, Savale L, Sitbon O, Fadel E, Humbert M, Simonneau G.

Eur Respir J. 2019 May 18;53(5). pii: 1802095. doi: 10.1183/13993003.02095-2018. Print 2019 May.

PMID:
31023842
18.

Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".

Guignabert C, Tu L, Feige JJ, Humbert M, Bailly S.

Circ Res. 2019 Apr 26;124(9):e82-e83. doi: 10.1161/CIRCRESAHA.119.315053. No abstract available.

PMID:
31021726
19.

[New insights in the pathogenesis of pulmonary arterial hypertension].

Bordenave J, Tu L, Savale L, Huertas A, Humbert M, Guignabert C.

Rev Mal Respir. 2019 Apr;36(4):433-437. doi: 10.1016/j.rmr.2019.03.003. Epub 2019 Apr 19. French.

PMID:
31010759
20.

An insider view on the World Symposium on Pulmonary Hypertension.

Humbert M, Galiè N, McLaughlin VV, Rubin LJ, Simonneau G.

Lancet Respir Med. 2019 Jun;7(6):484-485. doi: 10.1016/S2213-2600(19)30111-0. Epub 2019 Apr 4. No abstract available.

PMID:
30956061
21.

The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats.

Piquereau J, Boet A, Péchoux C, Antigny F, Lambert M, Gressette M, Ranchoux B, Gambaryan N, Domergue V, Mumby S, Montani D, Adcock IM, Humbert M, Garnier A, Rucker-Martin C, Perros F.

Int J Mol Sci. 2019 Mar 27;20(7). pii: E1527. doi: 10.3390/ijms20071527.

22.

IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.

Humbert M, Bousquet J, Bachert C, Palomares O, Pfister P, Kottakis I, Jaumont X, Thomsen SF, Papadopoulos NG.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1418-1429. doi: 10.1016/j.jaip.2019.02.030. Epub 2019 Mar 27. Review.

23.

Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease.

Günther S, Perros F, Rautou PE, Girerd B, Ghigna MR, Cazals-Hatem D, Lau EM, Dorfmüller P, Sitbon O, Valla DC, Humbert M, Montani D.

Am J Pathol. 2019 Jun;189(6):1159-1175. doi: 10.1016/j.ajpath.2019.02.007. Epub 2019 Mar 26. Review.

PMID:
30926335
24.

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Humbert M, Farber HW, Ghofrani HA, Benza RL, Busse D, Meier C, Hoeper MM.

Eur Respir J. 2019 Jun 5;53(6). pii: 1802004. doi: 10.1183/13993003.02004-2018. Print 2019 Jun.

25.

The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!

Hoeper MM, Humbert M.

Eur Respir J. 2019 Mar 28;53(3). pii: 1900038. doi: 10.1183/13993003.00038-2019. Print 2019 Mar. No abstract available.

PMID:
30923177
26.

Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype.

Weatherald J, Montani D, Humbert M.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):406-408. doi: 10.1164/rccm.201901-0248ED. No abstract available.

27.

Pulmonary Arterial Histologic Lesions in Patients With COPD With Severe Pulmonary Hypertension.

Bunel V, Guyard A, Dauriat G, Danel C, Montani D, Gauvain C, Thabut G, Humbert M, Castier Y, Dorfmüller P, Mal H.

Chest. 2019 Jul;156(1):33-44. doi: 10.1016/j.chest.2019.02.333. Epub 2019 Mar 11.

PMID:
30872017
28.

In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis.

Coppard C, Hannani D, Humbert M, Gauthier V, Plumas J, Merlin E, Gabert F, Chaperot L.

J Clin Apher. 2019 Aug;34(4):450-460. doi: 10.1002/jca.21698. Epub 2019 Mar 12.

PMID:
30860623
29.

Entry Exclusion of Conjugative Plasmids of the IncA, IncC, and Related Untyped Incompatibility Groups.

Humbert M, Huguet KT, Coulombe F, Burrus V.

J Bacteriol. 2019 Apr 24;201(10). pii: e00731-18. doi: 10.1128/JB.00731-18. Print 2019 May 15.

PMID:
30858294
30.

Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic study.

Cornet L, Khouri C, Roustit M, Guignabert C, Chaumais MC, Humbert M, Revol B, Despas F, Montani D, Cracowski JL.

Eur Respir J. 2019 May 9;53(5). pii: 1802472. doi: 10.1183/13993003.02472-2018. Print 2019 May.

PMID:
30846469
31.

PyLAT: Python LAMMPS Analysis Tools.

Humbert MT, Zhang Y, Maginn EJ.

J Chem Inf Model. 2019 Apr 22;59(4):1301-1305. doi: 10.1021/acs.jcim.9b00066. Epub 2019 Mar 15.

PMID:
30844269
32.

Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension: a multicentre study.

Vadasz Z, Balbir Gurman A, Meroni P, Farge D, Levi Y, Ingegnoli F, Braun-Moscovici Y, Rosner I, Slobodin G, Rozenbaum M, Jiries N, Kaly L, Boulman N, Zilber K, Ginsberg S, Awisat A, Goldberg Y, Lurie M, Ghigna MR, Guignabert C, Humbert M, Rimar D.

Rheumatology (Oxford). 2019 Feb 15. pii: kez035. doi: 10.1093/rheumatology/kez035. [Epub ahead of print]

PMID:
30770717
33.

Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.

Zhou M, Humbert M, Mukhtar MM, Scinto HB, Vyas HK, Lakhashe SK, Byrareddy SN, Maurer G, Thorat S, Owuor J, Lai Z, Chen Y, Griffiths A, Chenine AL, Gumber S, Villinger F, Montefiori D, Ruprecht RM.

J Virol. 2019 Apr 17;93(9). pii: e02267-18. doi: 10.1128/JVI.02267-18. Print 2019 May 1.

PMID:
30760566
34.

Inhibition of B cell-dependent lymphoid follicle formation prevents lymphocytic bronchiolitis after lung transplantation.

Smirnova NF, Conlon TM, Morrone C, Dorfmuller P, Humbert M, Stathopoulos GT, Umkehrer S, Pfeiffer F, Yildirim AÖ, Eickelberg O.

JCI Insight. 2019 Feb 7;4(3). pii: 123971. doi: 10.1172/jci.insight.123971. [Epub ahead of print]

35.

Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma.

Djavaheri-Mergny M, Giuriato S, Tschan MP, Humbert M.

Cells. 2019 Jan 30;8(2). pii: E103. doi: 10.3390/cells8020103. Review.

36.

Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.

Tu L, Desroches-Castan A, Mallet C, Guyon L, Cumont A, Phan C, Robert F, Thuillet R, Bordenave J, Sekine A, Huertas A, Ritvos O, Savale L, Feige JJ, Humbert M, Bailly S, Guignabert C.

Circ Res. 2019 Mar 15;124(6):846-855. doi: 10.1161/CIRCRESAHA.118.313356.

PMID:
30636542
37.

[Year in review : geriatrics].

Stamm E, Acchini A, Da Costa A, Besse S, Christou F, Launay C, Balmer P, Humbert M, Nguyen S, Major K, Bosshard W, Büla C.

Rev Med Suisse. 2019 Jan 9;15(N° 632-633):50-52. Review. French.

PMID:
30629369
38.

Golden Ratio and the Proportionality Between Pulmonary Pressure Components in Pulmonary Arterial Hypertension.

Chemla D, Boulate D, Weatherald J, Lau EMT, Attal P, Savale L, Montani D, Fadel E, Mercier O, Sitbon O, Humbert M, Hervé P.

Chest. 2019 May;155(5):991-998. doi: 10.1016/j.chest.2018.12.006. Epub 2018 Dec 27.

PMID:
30594558
39.

Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.

Hautefort A, Mendes-Ferreira P, Sabourin J, Manaud G, Bertero T, Rucker-Martin C, Riou M, Adão R, Manoury B, Lambert M, Boet A, Lecerf F, Domergue V, Brás-Silva C, Gomez AM, Montani D, Girerd B, Humbert M, Antigny F, Perros F.

Circulation. 2019 Feb 12;139(7):932-948. doi: 10.1161/CIRCULATIONAHA.118.033744.

PMID:
30586714
40.

Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases.

Eyries M, Montani D, Nadaud S, Girerd B, Levy M, Bourdin A, Trésorier R, Chaouat A, Cottin V, Sanfiorenzo C, Prevot G, Reynaud-Gaubert M, Dromer C, Houeijeh A, Nguyen K, Coulet F, Bonnet D, Humbert M, Soubrier F.

Eur Respir J. 2019 Mar 14;53(3). pii: 1801371. doi: 10.1183/13993003.01371-2018. Print 2019 Mar.

PMID:
30578383
41.

Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.

Günther S, Bordenave J, Hua-Huy T, Nicco C, Cumont A, Thuillet R, Tu L, Quatremarre T, Guilbert T, Jalce G, Batteux F, Humbert M, Savale L, Guignabert C, Dinh-Xuan AT.

Int J Mol Sci. 2018 Dec 18;19(12). pii: E4105. doi: 10.3390/ijms19124105.

42.

Warming up the tumor microenvironment in order to enhance immunogenicity.

Humbert M, Hugues S.

Oncoimmunology. 2018 Oct 1;8(1):e1510710. doi: 10.1080/2162402X.2018.1510710. eCollection 2019.

43.

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.

Humbert M, Guignabert C, Bonnet S, Dorfmüller P, Klinger JR, Nicolls MR, Olschewski AJ, Pullamsetti SS, Schermuly RT, Stenmark KR, Rabinovitch M.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801887. doi: 10.1183/13993003.01887-2018. Print 2019 Jan.

44.

Functional interaction between PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension.

Quatredeniers M, Nakhleh MK, Dumas SJ, Courboulin A, Vinhas MC, Antigny F, Phan C, Guignabert C, Bendifallah I, Vocelle M, Fadel E, Dorfmüller P, Humbert M, Cohen-Kaminsky S.

Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L445-L455. doi: 10.1152/ajplung.00537.2017. Epub 2018 Dec 13.

PMID:
30543306
45.

Biomarker-based corticosteroid adjustment in severe asthma: a modified Delphi consensus.

Gallagher NE, Hanratty CE, Humbert M, Bel E, Djukanovic R, Hudson V, Amos N, Heaney LG.

ERJ Open Res. 2018 Dec 7;4(4). pii: 00081-2018. doi: 10.1183/23120541.00081-2018. eCollection 2018 Oct.

46.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium.

Lancet Respir Med. 2019 Mar;7(3):227-238. doi: 10.1016/S2213-2600(18)30409-0. Epub 2018 Dec 5.

47.

Pulmonary arterial hypertension in adults

Bourlier D, Humbert M, Savale L.

Rev Prat. 2017 Dec;67(10):e471-e478. French. No abstract available.

PMID:
30512622
48.

Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension.

Poble PB, Phan C, Quatremare T, Bordenave J, Thuillet R, Cumont A, Huertas A, Tu L, Dorfmüller P, Humbert M, Ghigna MR, Savale L, Guignabert C.

FASEB J. 2019 Mar;33(3):3670-3679. doi: 10.1096/fj.201801659R. Epub 2018 Nov 27.

PMID:
30481487
49.

[IL6R is the key therapeutical target in pulmonary arterial hypertension].

Tu L, Phan C, Humbert M, Guignabert C.

Med Sci (Paris). 2018 Oct;34(10):765-768. doi: 10.1051/medsci/2018201. Epub 2018 Nov 19. French. No abstract available.

PMID:
30451672
50.

[Staying at home : which dimensions to assess in older persons ?]

Büla C, Humbert M, Nguyen S, Major K, Joly Schwartz C.

Rev Med Suisse. 2018 Nov 7;14(626):1993-1997. French.

PMID:
30422417

Supplemental Content

Loading ...
Support Center